Skip to main content

Table 2 Multiple regression analysis

From: Retrospective feasibility study of simultaneous integrated boost in cervical cancer using tomotherapy: the impact of organ motion and tumor regression

CTV under-dosage

p-value

Rectum moved anteriorly

0.029

Rectum reduced in volume

0.01

Reduction in the Dice’s coefficient

0.005

Bowel doses increase

p-value

Bladder moved anteriorly

0.01

Bladder reduced in volume

0.0046

Rectal doses increase

p-value

Rectal volume increased

0.0026

CTV-SIB moved anteriorly

0.00001

Bladder doses increase

p-value

Bladder moved posteriorly

0.01

CTV-SIB reduced in volume

0.01

  1. Independent factors contributing to the clinical target volume - simultaneous integrated boost (CTV-SIB) under-dosage and organs at risk (OAR) over-dosage.